If you have room in your portfolio for some new additions in November, then you might want to consider the ASX growth shares listed below.
They have recently been named as buys by experts and tipped to climb meaningfully higher from current levels. Here's what you need to know about them:
Cochlear Limited (ASX: COH)
The first ASX growth share that has been named as a buy is Cochlear. It is one of the world's leading hearing solutions companies. It has been tipped to continue its growth long into the future thanks to its portfolio of world class products in an industry with high barriers of entry. Particularly given how the industry is benefiting from favourable tailwinds such as ageing populations and a growing middle class.
Goldman Sachs is bullish on Cochlear. Its analysts currently have a buy rating and $247.00 price target on its shares.
IDP Education Ltd (ASX: IEL)
Another ASX growth share that has been named as a buy is IDP Education. It is a language testing and student placement company and a co-owner of the IELTS test. This is the English test that is trusted by more governments, universities, and organisations than any other.
Goldman Sachs is a big fan of the company and is expecting strong underlying system demand to result its rapid earnings growth through to FY 2025. Goldman has a buy rating and $36.00 price target on the company's shares.
Life360 Inc (ASX: 360)
A final ASX growth share that analysts have tipped as a buy is Life360. It is a technology company that operates in the digital consumer subscription services market, with a focus on products and services for digitally native families. The company's flagship product is the Life360 app, which has a whopping 40 million+ active users. It offers families features such as communications, driver safety, and location sharing.
Analysts at Bell Potter are very positive on the company. This is due to its huge total addressable market and material cross selling opportunities. Bell Potter has a buy rating and $8.25 price target on its shares.
